Nuvation Bio (Nuvation Bio) Cash-to-Debt : No Debt ⁽¹⁾ (As of Sep. 2021)

View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Nuvation Bio's cash to debt ratio for the quarter that ended in Sep. 2021 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Nuvation Bio could pay off its debt using the cash in hand for the quarter that ended in Sep. 2021.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Nuvation Bio's Cash-to-Debt or its related term are showing as below:

NUVB.WS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04 Med: No Debt Max: No Debt
Current: 250.54

During the past 2 years, Nuvation Bio's highest Cash to Debt Ratio was No Debt. The lowest was 0.04. And the median was No Debt.

NUVB.WS's Cash-to-Debt is not ranked
in the Biotechnology industry.
Industry Median: 6.46 vs NUVB.WS: 250.54

Nuvation Bio Cash-to-Debt Historical Data

The historical data trend for Nuvation Bio's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Nuvation Bio Cash-to-Debt Chart

Nuvation Bio Annual Data

Trend

Dec20

Dec21

Cash-to-Debt

No Debt

250.54

Nuvation Bio Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Cash-to-Debt	Get a 7-Day Free Trial			No Debt	No Debt	No Debt	No Debt	250.54

Competitive Comparison of Nuvation Bio's Cash-to-Debt

For the Biotechnology subindustry, Nuvation Bio's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuvation Bio's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Cash-to-Debt falls into.

Nuvation Bio Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Nuvation Bio's Cash to Debt Ratio for the fiscal year that ended in Dec. 2020 is calculated as:

Nuvation Bio had no debt ⁽¹⁾.

Nuvation Bio's Cash to Debt Ratio for the quarter that ended in Sep. 2021 is calculated as:

Nuvation Bio had no debt ⁽¹⁾.

Nuvation Bio (NYSE:NUVB.WS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Nuvation Bio Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1500 Broadway, Suite 1401, New York, NY, USA, 10036

Website

https://www.nuvationbio.com

Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.